Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

Grants and Contracts Details

StatusFinished
Effective start/end date5/2/114/30/14

Funding

  • AstraZeneca Pharmaceuticals AB: $100,000.00